Sanofi Consumer Healthcare

Sanofi Consumer Healthcare

4,940.50
+38.50
(0.79%)
Market Cap
11,378.30 Cr
EPS
78.59
PE Ratio
57.02
Dividend Yield
1.12 %
Industry
Healthcare
52 Week High
5,894.50
52 Week Low
4,211.55
PB Ratio
43.89
Debt to Equity
0.04
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from1 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %

Company News

View All News
Caret
positive
Sanofi Consumer Healthcare India Limited appointed Mr. Narahari Naidu as Chief Financial Officer effective August 4th, 2025, for a six-month term. The appointment was approved by the Board of Directors based on recommendations from the Nomination and Remuneration Committee and in consultation with the Audit Committee. Naidu brings over 14 years of experience across healthcare/pharmaceuticals, manufacturing, and consulting sectors, with expertise in Finance & Accounts, Procurement, Investor Relations, Mergers & Acquisitions, Banking & Treasury, and IPO management. He previously served as Group CFO for entities operating across India, UK and USA.
positive
Sanofi Consumer Healthcare India Limited reported revenue from operations of ₹2,209 million for the quarter ended June 30, 2025, representing a 28% increase from ₹1,723 million in the same quarter last year. Net profit rose 21% to ₹607 million compared to ₹290 million in the previous year quarter. For the half-year period, revenue remained flat at ₹3,935 million versus ₹3,939 million, while profit increased to ₹1,107 million from ₹917 million. The company recorded an exceptional gain of ₹66 million from reversing excess demerger-related provisions. Basic and diluted earnings per share for the quarter stood at ₹26.36 compared to ₹12.58 in the prior year. The company successfully relaunched Combiflam Suspension during the quarter and continues efforts to bring back other recalled products to market.
neutral
Sanofi Consumer Healthcare India Reports Q4 Financial ResultsMay 02, 2025
Sanofi Consumer Healthcare India has released its Q4 financial results. The company's EBITDA decreased to 640 million rupees from 818 million rupees year-over-year. However, the EBITDA margin slightly improved to 37.08% from 36.91%. Net profit fell to 500 million rupees from 627 million rupees year-over-year, but increased from 443 million rupees quarter-over-quarter. Revenue for Q4 was 1.7 billion rupees, down from 2.2 billion rupees in the same period last year.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,586.70
#1 3,80,702.50
33.18
#1 54,729.00
9.71
#1 10,980
-19.84
51.86
5,689.50
1,51,038.30
65.50
9,712.00
18.67
2,191
26.74
36.39
1,499.40
1,21,107.70
22.45
28,409.50
7.12
5,291
9.88
38.89
3,561.00
1,20,520.40
59.72
11,539.40
6.99
1,911
19.91
42.61
1,253.10
1,04,580.10
#1 18.40
33,741.20
16.73
5,725
1.26
46.51
2,482.90
1,02,476.40
54.18
12,744.20
#1 20.90
2,007
-18.14
44.66
975.00
98,107.80
21.07
23,511.00
18.55
4,615
2.60
50.50
1,919.80
87,676.40
23.72
22,909.50
13.74
3,306
#1 51.64
46.16
5,433.00
64,959.70
28.53
13,458.30
3.70
2,216
21.39
61.31
1,090.00
63,307.40
18.84
32,345.60
9.43
3,484
-10.24
53.78
Forecast
Actual
Growth Rate
Revenue Growth
31.81 %
Net Income Growth
9.76 %
Cash Flow Change
1,09,850.00 %
ROE
-16.53 %
ROCE
-18.07 %
EBITDA Margin (Avg.)
-

Yearly Financial Results

Annual Financials
2023
2024
TTM
Revenue
560
738
751
Expenses
337
454
469
EBITDA
223
284
282
Operating Profit %
39 %
37 %
36 %
Depreciation
2
5
8
Interest
0
4
5
Profit Before Tax
219
247
270
Tax
54
66
70
Net Profit
165
181
200
EPS in ₹
71.60
78.59
86.80

Balance Sheet

Balance Sheet
2023
2024
Total Assets
345
431
Fixed Assets
5
29
Current Assets
335
392
Capital Work in Progress
3
1
Investments
0
0
Other Assets
338
402
Total Liabilities
345
431
Current Liabilities
130
131
Non Current Liabilities
8
28
Total Equity
208
273
Reserve & Surplus
183
250
Share Capital
2
23

Cash Flow

Cash Flow
2023
2024
Net Cash Flow
2
325
Investing Activities
0
2
Operating Activities
-0
439
Financing Activities
2
-116

Share Holding

% Holding
Jun 2024
Sept 2024
Oct 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
60.40 %
60.40 %
60.40 %
60.40 %
60.40 %
71.27 %
FIIs
0.00 %
5.22 %
4.87 %
4.42 %
4.53 %
3.24 %
DIIs
20.87 %
24.03 %
24.51 %
25.35 %
25.48 %
16.89 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
7.71 %
7.53 %
7.41 %
7.01 %
6.58 %
6.30 %
Others
11.03 %
2.83 %
2.82 %
2.83 %
3.01 %
2.30 %
No of Share Holders
61,091
61,091
57,598
55,734
51,859
49,632

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 55 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.14 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
12 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Nov 2024 4,864.05 4,911.45
20 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
20 Feb 2025 4,714.65 4,743.70
17 Apr 2025 DIVIDEND Dividend
₹ 55.00 /share
17 Apr 2025 4,743.70 4,984.00
02 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
02 May 2025 4,940.10 4,942.35
05 May 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
05 May 2025 4,750.15 4,938.45
04 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
04 Aug 2025 4,968.40 4,864.10

Announcements

Closure of Trading Window13 hours ago
Announcement under Regulation 30 (LODR)-Change in ManagementSep 01, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 06, 2025
Appointment Of Chief Financial Officer - Key Managerial PersonnelAug 04, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 04, 2025
Outcome Of Board Meeting Held On Monday 4Th August 2025Aug 04, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Monday 4Th August 2025Aug 04, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Monday 4Th August 2025Aug 04, 2025
Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th June 2025Jul 29, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 14, 2025
Closure of Trading WindowJun 26, 2025
Disclosure Under Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015Jun 13, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jun 13, 2025
Post-Offer AdvertisementMay 24, 2025
Updates on Open OfferMay 10, 2025
Updates on Open OfferMay 09, 2025
Updates on Open OfferMay 08, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportMay 07, 2025
Updates on Open OfferMay 07, 2025
Updates on Open OfferMay 06, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMMay 05, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 03, 2025
Updates on Open OfferMay 03, 2025
Updates on Open OfferMay 03, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 02, 2025
Board Meeting Outcome For Consideration And Approval Of Unaudited Financial Results For The Quarter Ended 31St March 2025May 02, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday 2Nd May 2025May 02, 2025
Updates on Open OfferMay 02, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 01, 2025
Updates on Open OfferApr 30, 2025
Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of Unaudited Financial Results For The Quarter Ended 31St March 2025Apr 25, 2025
Updates on Open OfferApr 24, 2025
Corrigendum To The Annual Report For Financial Year 2024Apr 23, 2025
Reg. 34 (1) Annual Report.Apr 23, 2025
Letter of OfferApr 16, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 15, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 13, 2025
Business Responsibility and Sustainability Reporting (BRSR)Apr 12, 2025
Shareholder Meeting - AGM On May 5 2025Apr 12, 2025
Reg. 34 (1) Annual Report.Apr 12, 2025
Newspaper Publication Of Recommendations By The Committee Of Independent Directors Pursuant To Regulation 26(7) Of The SEBI (SAST) Regulations 2011 Is Enclosed.Apr 11, 2025
Announcement under Regulation 30 (LODR)-Open Offer - UpdatesApr 10, 2025
Intimation For Change In Record Date For DividendApr 09, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementApr 04, 2025
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Apr 04, 2025
Announcement under Regulation 30 (LODR)-Resignation of DirectorApr 04, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotMar 30, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMar 30, 2025
Closure of Trading WindowMar 27, 2025
Intimation Of Second (2Nd) Annual General Meeting Of The CompanyMar 27, 2025

Technical Indicators

RSI(14)
Neutral
36.90
ATR(14)
Volatile
143.09
STOCH(9,6)
Oversold
17.15
STOCH RSI(14)
Oversold
4.45
MACD(12,26)
Bearish
-35.37
ADX(14)
Weak Trend
19.26
UO(9)
Bearish
45.99
ROC(12)
Downtrend And Accelerating
-3.83
WillR(14)
Neutral
-70.35

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bajaj Finserv Small Cap Fund Direct-Growth
1.06%
18549
0.76%
1.06%
ICICI Prudential Smallcap Fund Direct Plan-Growth
1.23%
-4219
0.05%
-0.10%
Aditya Birla Sun Life Large Cap Direct Fund-Growth
0.53%
3567
0.04%
-0.02%
Aditya Birla Sun Life MNC Fund Direct-Growth
0.69%
3346
0.09%
-0.01%
Motilal Oswal Quant Fund Direct-Growth
1.19%
3205
1.19%
1.19%
Bajaj Finserv Flexi Cap Fund Direct-Growth
1.00%
2405
0.05%
-0.12%
Motilal Oswal Nifty Microcap 250 Index Fund Direct - Growth
0.64%
846
0.06%
-0.03%
Baroda BNP Paribas Midcap Fund Direct-Growth
1.04%
764
0.08%
-0.05%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-Growth
1.17%
482
0.12%
-0.09%
UTI Dividend Yield Fund Direct-Growth
0.52%
360
0.06%
0.03%
UTI Healthcare Fund Direct-Growth
1.11%
153
0.09%
-0.12%
Aditya Birla Sun Life Small Cap Fund Direct-Growth
1.24%
-34
0.11%
-0.04%
Angel One Nifty Total Market Index Fund Direct - Growth
0.02%
2
0.00%
0.00%
Groww Nifty Total Market Index Fund Direct - Growth
0.02%
2
0.00%
0.00%
Bandhan Nifty Total Market Index Fund Direct-Growth
0.02%
1
0.00%
-0.01%
LIC MF Small Cap Fund Direct - Growth
0.00%
0
0.00%
0.00%
Nippon India Multi Cap Fund Direct-Growth
0.17%
0
0.01%
-0.02%
Bajaj Finserv Multi Asset Allocation Fund Direct-Growth
0.89%
0
0.05%
-0.07%
Bajaj Finserv Large and Mid Cap Fund Direct-Growth
0.44%
0
0.03%
0.04%
Baroda BNP Paribas Small Cap Fund Direct - Growth
1.08%
0
0.09%
-0.04%
Baroda BNP Paribas Value Fund Direct - Growth
1.10%
0
0.09%
-0.01%
Bajaj Finserv Healthcare Fund Direct-Growth
1.98%
0
0.16%
-0.19%
HDFC Multi Asset Fund Direct-Growth
0.00%
0
0.00%
0.00%
HDFC Retirement Savings Fund - Hybrid Debt Plan Direct-Growth
0.00%
0
0.00%
0.00%
HDFC Retirement Savings Fund - Hybrid Equity Plan Direct-Growth
0.00%
0
0.00%
0.00%